These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 4303692)
41. [Binary ethyleneimine as an inactivator of the foot-and-mouth disease virus]. Tekerlekov P; Veleva E Vet Med Nauki; 1985; 22(3):3-8. PubMed ID: 2986348 [TBL] [Abstract][Full Text] [Related]
42. Foot-and-mouth disease vaccine potency testing: the influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose-response curve in cattle. Jamal SM; Bouma A; van den Broek J; Stegeman A; Chénard G; Dekker A Vaccine; 2008 Nov; 26(50):6317-21. PubMed ID: 18822336 [TBL] [Abstract][Full Text] [Related]
43. Foot and mouth disease virus production on microcarrier-grown cells. Meignier B; Mougeot H; Favre H Dev Biol Stand; 1980; 46():249-56. PubMed ID: 6245001 [TBL] [Abstract][Full Text] [Related]
44. [Diagnosis and control of bovine enzootic leukosis. 4. Comparison of antibody formation following inoculation of the Riems concentrated foot-and-mouth disease vaccine in clinicially healthy and in pre-leukotic cattle]. Seils H; Wittmann W; Weyhe D Arch Exp Veterinarmed; 1971 Jun; 25(3):581-6. PubMed ID: 4330772 [No Abstract] [Full Text] [Related]
45. [The disinfectant activity of iosan against foot and mouth disease virus]. Böhm HO Dtsch Tierarztl Wochenschr (1946); 1970 Aug; 77(15):377-82. PubMed ID: 4317444 [No Abstract] [Full Text] [Related]
46. Development of an inhibition ELISA test for the detection of non-capsid polyprotein 3ABC in viral suspensions destined for inactivated foot-and-mouth disease vaccines. Bergmann IE; Neitzert E; Malirat V; de Mendonça Campos R; Pulga M; Muratovik R; Quintino D; Morgados JC; Oliveira M; de Lucca Neto D Dev Biol (Basel); 2006; 126():241-50; discussion 327. PubMed ID: 17058500 [TBL] [Abstract][Full Text] [Related]
47. [Studies on the suitability of tissue culture neutralization tests in the government etesting of adsorbed foot-and mouth disease vaccines. 1. The content of neutralizing antibody in the serum of cattle after vaccination with adsorbed vaccine against type O2 virus in comparison with the direct immunity testing in cattle]. Rüting E; Seils H; Weyhe D; Benndorf E Arch Exp Veterinarmed; 1969; 23(4):827-38. PubMed ID: 4319494 [No Abstract] [Full Text] [Related]
48. [On the production of monovalent foot-and-mouth disease vaccine concentrate from tissue culture virus type O]. Mitev G; Wassilewa L; Tekerlekov P Arch Exp Veterinarmed; 1966 Mar; 20(1):85-90. PubMed ID: 4293436 [No Abstract] [Full Text] [Related]
49. [Examination of foot-and-mouth disease virus strains with regard to their suitability for modified virus vaccine preparation]. Wittmann G; Ahl R; Bauer K Bull Off Int Epizoot; 1966; 65(11):1901-20. PubMed ID: 4297170 [No Abstract] [Full Text] [Related]
50. Experiments on an early protection against foot-and-mouth disease virus. Liebermann HT; Thalmann G; Bartels T; Nöckler A Acta Virol; 1993; 37(2-3):181-3. PubMed ID: 8105663 [TBL] [Abstract][Full Text] [Related]
51. [Deviations of a 1st order reaction in the inactivation of foot-and-mouth disease (FMS) virus with hydroxylamine]. Wittmann G; Bauer K Zentralbl Bakteriol Orig; 1968; 207(2):259-61. PubMed ID: 4314371 [No Abstract] [Full Text] [Related]
53. Residual foot-and-mouth disease virus antibodies in French cattle and sheep six years after the vaccination ban. Remond M; Kaiser C; Lebreton FO; Moutou F; Crucière C Vet Res; 2001; 32(1):81-6. PubMed ID: 11254180 [TBL] [Abstract][Full Text] [Related]
54. [Types and subtypes of foot-and-mouth disease virus and their practical significance]. Tekerlekov P Vet Med Nauki; 1977; 14(10):109-15. PubMed ID: 76365 [No Abstract] [Full Text] [Related]
55. [Determination of effectiveness of FMD vaccine type Asia 1 in neutralization tests in cattle]. Dimitriadis IA Berl Munch Tierarztl Wochenschr; 1993 Apr; 106(4):124-7. PubMed ID: 8387775 [TBL] [Abstract][Full Text] [Related]
56. Proceedings: Quantitative assay of the immunizing dose of monovalent vaccines against foot-and-mouth disease prepared from the virus propagated on cattle tongue mucosa and in culture after Frenkel. Wiśniewski J; Kobusiewicz T; Szkilnik S; Baranowski C; Jankowska J; Labecka W Acta Microbiol Pol A; 1974; 6(1):131. PubMed ID: 4364054 [No Abstract] [Full Text] [Related]
57. Comparison of the inactivation and antigenicity of foot-and-mouth-disease virus by acetylethyleneimine and by combined effect of ultraviolet light and beta-propiolactone. Fellowes ON J Immunol; 1965 Dec; 95(6):1100-6. PubMed ID: 4285068 [No Abstract] [Full Text] [Related]
58. [Immunobiological properties of strains of foot-and-mouth disease virus multiplying in cell cultures]. Efimov NI; Siusiukin AA; Shvetsova RV; Serodzhev AT Veterinariia; 1975 May; (5):53-5. PubMed ID: 174272 [No Abstract] [Full Text] [Related]
59. [Immunological variability in the type of aphthous virus, its limits and practical significance]. Muntiu N; Dohotaru V; Bercan A; Tomescu A Bull Off Int Epizoot; 1969; 71(3-4):249-61. PubMed ID: 4323520 [No Abstract] [Full Text] [Related]
60. [Determining the standard and variant foot-and-mouth disease virus--the basis of specific prevention]. Onufriev VP; Dudnikov AI; Shvetsov IuF; Sobko AI Veterinariia; 1966 Jan; 43(1):106-7. PubMed ID: 4293888 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]